Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review.

@article{Anjum2017CurrentSA,
  title={Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review.},
  author={Komal Anjum and Bibi Ibtesam Shagufta and Syed Qamar Abbas and Seema Patel and Ishrat Khan and Sayed Asmat Ali Shah and Najeeb Akhter and Syed Shams Ul Hassan},
  journal={Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie},
  year={2017},
  volume={92},
  pages={681-689}
}
Glioblastoma multiforme (GBM) is the deadliest form of heterogeneous brain cancer. It affects an enormous number of patients every year and the survival is approximately 8 to 15 months. GBM has driven by complex signaling pathways and considered as a most challenging to treat. Standard treatment of GBM includes surgery, radiation therapy, chemotherapy and also the combined treatment. This review article described inter and intra- tumor heterogeneity of GMB. In addition, recent chemotherapeutic… CONTINUE READING
Highly Cited
This paper has 130 citations. REVIEW CITATIONS
Recent Discussions
This paper has been referenced on Twitter 6 times over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

130 Citations

010020020172018
Citations per Year
Semantic Scholar estimates that this publication has 130 citations based on the available data.

See our FAQ for additional information.

Similar Papers

Loading similar papers…